AI Image
Dad claims he went suddenly, permanently blind from Ozempic - in one of hundreds of lawsuits against GLP-1 makers
Yahoo • • health
Key Points:
- Edward Gillen, a Massachusetts man, lost his vision suddenly and was diagnosed with nonarteritic anterior ischemic optic neuropathy (NAION), which doctors linked to his use of the diabetes drug Ozempic, a GLP-1 receptor agonist.
- NAION causes sudden, painless vision loss due to blocked blood flow to the optic nerve, and currently has no treatment; recent studies suggest a possible but low risk association with GLP-1 drugs like semaglutide.
- Over 200 lawsuits have been filed against manufacturers Novo Nordisk and Eli Lilly, alleging these companies failed to warn about the risk of NAION and that their drugs are defectively dangerous.
- Novo Nordisk denies the lawsuits' claims, emphasizing the drug’s established safety profile backed by extensive clinical data and millions of patient-years of use.
- Experts note the challenge in determining causality since patients on GLP-1 drugs often have pre-existing risk factors for NAION, such as diabetes, obesity, and hypertension.
